Presentations

1. Hammond WP , Kaplan A, Kaplan S, and Kaushansky K. Thrombopoietin (TPO) activates platelets in vitro. Presented at the 36th Annual Meeting of American Society of Hematology. December 2-6, 1994. Nashville, Tennessee
2. Kaplan A, Kaplan S, Marcoe KF, Sauvage LR, Hammond WP. Identification of potential predisposition to clinical atheroclerosisis: A concept based on integration of significant blood parameters with platelet aggregation scores. Presented at the Second Annual Meeting of the International Academy of Clinical and Applied Thrombosis/Hemostasis. November 1996: Frankfurt, Germany
3. Kaplan A, Kaplan S, Marcoe KF, Sauvage LR, Hammond WP. Modified laboratory technique for measuring platelet aggregability. Presented at the Second Annual Meeting of the International Academy of Clinical and Applied Thrombosis/Hemostasis. November 1996: Frankfurt, Germany
4. Kaplan A, Kaplan S, Marcoe KF, Sauvage LR, Hammond WP. The Effect of hematopoietic growth factors on platelet aggregability. Presented at the Third Annual Meeting of the International Academy of Clinical and Applied Thrombosis/Hemostasis. November 1997: St. Petersburg, FL, USA
5. Kaplan A, Kaplan S, Marcoe KF, Sauvage LR, Hammond WP. Multifactorial risk assessment of clinical atherosclerosis in women based on the integration of fibrinogen and other hematological risk markers. Presented at the Fourth International Fibrinogen Symposium: Fibrinogen & Cardiovascular Diseases. February 1999: Paris, France.
6. Kaplan A, Kaplan S, Marcoe KF, Sauvage LR, Hammond W.P. Assessment of predictive power of the clinical atherosclerosis predisposition factor for identification of people at risk for developing cardiovascular disease. Presented at 5th International Symposium: Multiple Risk Factors in Cardiovascular Disease: Global Assessment and Intervention. October 1999: Venice, Italy